Celera and Merck Undertake Functional Genome Scan for Alzheimer's Targets

GenomeWeb Daily News: "Celera Diagnostics said today that it has entered into an agreement with Merck to identify novel targets for drug discovery and diagnostic markers related to Alzheimer's disease."